< Back to previous page
Researcher
Christophe Pannecouque
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Jul 2002 → Today
Projects
1 - 3 of 3
- An automated platform for multiparameter data collection on live pathogens of higher or unknown biosafety risk.From26 Jun 2014 → 31 Dec 2018Funding: Hercules - Large scale research infrastructure
- Mechanistic study on virus entry and replication. A fundamental approach to the development of new and specific antiviral chemotherapeutics.From1 Jan 2010 → 31 Dec 2014Funding: BOF - Concerted Research Project from 1994
- Identification of biomarkers and new therapeutic targets in HTLV-1-associated pathologies.From1 Jan 2010 → 31 Dec 2013Funding: FWO research project
Publications
301 - 310 of 399
- New Substituted Thiazol-2-ylidene-benzamides and Their Reaction with 1-Aza-2-azoniaallene Salts. Synthesis and anti-HIV Activity (vol 66b, pg 512, 2011)(2011)
Authors: Aamer Saeed, Najim A Al-Masoudi, Amjed A Ahmed, Christophe Pannecouque
Pages: 979 - 979 - Erratum: New substituted thiazol-2-ylidene-benzamides and their reaction with 1-Aza-2-azoniaallene salts. Synthesis and anti-HIV activity (Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences (2011) 66b (512-520))(2011)
Authors: Christophe Pannecouque
Pages: 979 - Synthesis and structure-activity relationship of novel diarylpyrimidines with hydromethyl linker (CH(OH)-DAPYs) as HIV-1 NNRTIs(2011)
Authors: Erik De Clercq, Jan Balzarini, Christophe Pannecouque
Pages: 5117 - 5124 - Synthesis and anti-HIV Activity of New Benzimidazole, Benzothiazole and Carbohyrazide Derivatives of the anti-Inflammatory Drug Indomethacin(2011)
Authors: Christophe Pannecouque
Pages: 953 - 960 - Substituted 2-aminothiazoles are exceptional inhibitors of neuronal degeneration in tau-driven models of Alzheimer's disease(2011)
Authors: Christophe Pannecouque, Arthur Van Aerschot
Pages: 386 - 392 - Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors(2011)
Authors: Christophe Pannecouque, Erik De Clercq
Pages: 4366 - 4376 - Structural investigation of the naphthyridone scaffold: identification of a 1,6-naphthyridone derivative with potent and selective anti-HIV activity(2011)
Authors: Dirk Daelemans, Christophe Pannecouque
Pages: 1249 - 1257 - A time-of-drug addition approach to target identification of antiviral compounds(2011)
Authors: Dirk Daelemans, Erik De Clercq, Christophe Pannecouque
Pages: 925 - 933 - Thiazolylthioacetamides as a novel class of potential antiviral agents(2011)
Authors: P Zhan, X Chen, X Liu, Christophe Pannecouque, Lieve Naesens, Erik De Clercq, A Liu, G Du
Pages: A67 - A67 - Synthesis and biological evaluation of 6-substituted 5-alkyl-2-(phenylaminocarbonylmethylthio)pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs(2011)
Authors: Christophe Pannecouque, Erik De Clercq
Pages: 826 - 833
Patents
1 - 7 of 7
- Antiviral activity of bicyclic heterocycles (Inventor)
- Antiviral activity of novel bicyclic heterocycles (Inventor)
- Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (Inventor)
- Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (Inventor)
- Antiviral activity of bicyclic heterocycles (Inventor)
- Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (Inventor)
- PHOSPHONATE NUCLEOSIDES USEFUL AS ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS, AND INTERMEDIATES FOR THEIR PRODUCTION (Inventor)